Nemera, a global leader in drug delivery devices, recently announced the groundbreaking ceremony for a new production hall at its La Verpillière site (Isère, France). This major 5,000 sqm extension, 4,500 sqm of which will be dedicated to manufacturing, marks an important milestone in the Group’s growth ambitions.

Construction work will take place throughout 2026, with production scheduled to start in the second half of 2027.
This project is fully aligned with Nemera’s industrial roadmap, which aims to double the size of the La Verpillière site by 2030, confirming its strategic role in the Group’s global development.

The expansion responds to rapidly growing global demand, in particular for injection pens used in the treatment of diabetes and obesity, two major public health challenges. It will sustainably increase production capacity to better support customers and meet patients’ needs.

At full capacity by 2028, the new production hall will create 150 additional jobs, strengthening a workforce that already exceeds 600 employees at La Verpillière. This recruitment momentum illustrates the Group’s commitment to local economic development and to enhancing the attractiveness of the region.

The future production hall has been designed to meet stringent environmental standards. Highly energy-efficient technologies have been selected to control energy consumption and reduce carbon footprint. The building will include 1,500 sqm of photovoltaic panels, and from 2027 its operations will fall within the scope of the ISO 14001 and ISO 50001 certifications already in place at the La Verpillière site.

The official groundbreaking ceremony took place on April 14, 2026, at the La Verpillière site, in the presence of Nemera representatives, industrial partners and local institutional stakeholders.

Julien Marion, Plant Director of Nemera La Verpillière, stated: “We are extremely proud of the devices we develop and manufacture at Nemera La Verpillière, as they help improve the health of millions of patients around the world every day. This new expansion reflects the trust our customers place in us and the quality of our teams’ work, whose expertise and rigor are essential to delivering projects of this scale.

We are also fortunate to be located at the heart of the CAPI, a dynamic industrial region that actively supports our development. Through this project, we are strengthening our contribution to the local economy as a major employer.”

Nemera is a world-leading provider of drug delivery device solutions. Our mission of putting patients first drives us to design and manufacture devices that maximize treatment efficacy. From early device strategy to state-of-the-art manufacturing, we are committed to delivering the highest quality standards to our customers.